Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PNC vs GSK✓SelectedUSD · GSKPNC vs GSK performance historyLatest closeAs of+0.55%11/13
Stock and ETF performance explorer

PNC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+116.1%
GSK return
+65.8%
Excess return
+50.3%
Maximum drawdown
-29.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.5%+0.5%0.0%+0.5%
7D+3.1%+1.1%+1.9%+3.0%
30D+7.6%+6.3%+1.3%+7.0%
3M-8.1%+1.8%-10.0%-8.4%
6M+12.6%+1.7%+10.9%+12.3%
YTD+15.0%+6.5%+8.4%+14.5%
1Y+30.4%+9.5%+20.9%+29.7%
3Y+116.1%+65.3%+50.8%+111.5%
All+116.1%+65.8%+50.3%+111.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling